Trina Forbes
About Trina Forbes
Trina Forbes is a Senior Associate at BeiGene with a strong legal background and extensive experience in the pharmaceutical industry.
Title and Current Position
Trina Forbes holds the title of Senior Associate at BeiGene. In this role, she utilizes her extensive background in regulatory affairs and the pharmaceutical industry to support the company's operations.
Education and Expertise
Trina Forbes earned a Bachelor of Business Administration (B.B.A.) from the University of Phoenix, graduating in 2005. Her expertise includes compiling submissions per regulations, quality product delivery to appropriate agencies, and proficiency in tools such as Insight Publisher, Product Lifecycle Management, Microsoft Word, Change Control, Validation, and Document Management.
Professional Background
Trina Forbes has a robust professional background in regulatory affairs within the pharmaceutical industry. She has held positions at various notable companies, including BeiGene, PRA Health Sciences, LIQUENT - a PAREXEL company, Grifols, and Novo Nordisk. She has over two decades of experience in producing quality submissions to regulatory agencies in compliance with industry standards.
Previous Roles in Pharmaceutical Industry
Trina Forbes's career includes significant roles in the pharmaceutical industry. She worked at PRA Health Sciences as a Senior Regulatory Publishing Specialist in 2020 and as a Regulatory Publishing Specialist 2 from 2018 to 2020. She served as a Senior Regulatory Affairs Associate at LIQUENT - a PAREXEL company from 2013 to 2018. She spent 14 years as a Senior RA Specialist at Grifols, from 1999 to 2013, and was a Documentation Coordinator at Novo Nordisk from 1996 to 1999.
Skills and Technical Proficiency
Trina Forbes demonstrates a strong skill set in regulatory affairs, with capabilities in Insight Publisher, Product Lifecycle Management, Microsoft Word, Change Control, Validation, and Document Management. Her technical proficiency supports her ability to compile and deliver regulatory submissions efficiently and accurately.